Document is current
Any future updates will be listed below
-
Authors
Hashimoto, Kenji https://orcid.org/0000-0002-8892-0439
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (21H02846, 23K17634)
- License Information
-
More Information
Article History
Received: 15 December 2023
Accepted: 22 January 2024
First Online: 27 February 2024
Declarations
:
: Dr. Hashimoto serves as one of the editors of this journal. Dr. Hashimoto is the inventor of filed patent applications on “The use of R-Ketamine in the treatment of psychiatric diseases,” “(S)-norketamine and salt thereof as pharmaceutical,” “R-Ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder,” “Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases,” and “R-Ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder” by the Chiba University. Dr. Hashimoto has also received speakers’ honoraria, consultant fee, or research support from Abbott, Boehringer-Ingelheim, Daiichi-Sankyo, Meiji Seika Pharma, Seikagaku Corporation, Dainippon-Sumitomo, Taisho, Otsuka, Murakami Farm, and Perception Neuroscience.
